Related Experiment Video
Updated: Jun 25, 2026
11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
18.4K
Hepatitis B virus genotypes influence clinical outcomes: A review
Carolina Fernandes da Silva1, Alexa Keeshan1,2, Curtis Cooper1,2
1Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Canadian Liver Journal
|November 29, 2023
Summary
Hepatitis B virus (HBV) genotypes influence disease progression and treatment response. This review analyzes how HBV genotype impacts outcomes like fibrosis, cirrhosis, and liver cancer, highlighting areas for future research.
Area of Science:
- Hepatology
- Virology
- Genetics
Background:
- Hepatitis B virus (HBV) affects nearly 300 million globally.
- HBV replication involves reverse transcription of an RNA intermediate, prone to mutations yielding diverse genotypes (A-I) and sub-genotypes.
- The impact of specific HBV genotypes on disease progression and outcomes remains unclear.
Purpose of the Study:
- To review and analyze the influence of HBV genotype on the risk of developing severe liver disease.
- To examine how HBV genotype affects patient responses to current and future therapies.
- To identify uncertainties and guide future research directions.
Main Methods:
- Systematic review of existing literature.
- Analysis of studies correlating HBV genotypes with clinical outcomes.
- Evaluation of treatment response data across different genotypes.
Main Results:
- HBV genotypes exhibit variations in geographic distribution and epidemiological impact.
- Evidence suggests a link between certain genotypes and the risk of fibrosis progression, cirrhosis, and hepatocellular carcinoma (HCC).
- Genotype may influence the efficacy of antiviral therapies and treatment outcomes.
Conclusions:
- HBV genotype is a significant factor influencing liver disease progression and hepatocellular carcinoma risk.
- Understanding genotype-specific effects is crucial for personalized treatment strategies and predicting therapeutic responses.
- Larger, diverse studies are needed to fully elucidate genotype-associated risks and optimize HBV management.
Keywords:
cirrhosisgenotypehepatitis B virus (HBV)hepatocellular carcinoma (HCC)interferon alpha (IFN-α)liver fibrosisnucleosidesMore Related Videos
Related Concept Videos
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...